Information about ROSC
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0630.838.609

VAT liability
Yes
Established
21-05-2015
Last balance sheet year
2024
Company size
Small 0 FTE
Full name
Reach Orphan Substances Consortium
Principal activity
Other professional, scientific and technical activities n.e.c.
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from ROSC

2024 2023 2022 2021
Equity 6,200 0 % 6,200 0 % 6,200 0 % 6,200
Gross margin -1,861 -10 % -1,694 -172 % 2,361 -34 % 3,577

Publications from ROSC

Date Publication
11-03-2021 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Resignations - Appointments - General meeting - Financial Year (NL)
28-03-2018 Registered Office (NL)
04-06-2015 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Reach Orphan Substances Consortium?
The VAT number of Reach Orphan Substances Consortium is BE 0630.838.609.
Wat is the PEPPOL ID of Reach Orphan Substances Consortium?
The PEPPOL ID of Reach Orphan Substances Consortium is 0208:0630838609. Log in or start a free trial to see the full overview.
When was Reach Orphan Substances Consortium founded?
Reach Orphan Substances Consortium was founded on 21-05-2015.
What is the address of Reach Orphan Substances Consortium?
The current registered office of Reach Orphan Substances Consortium is located at Haverstraat 8, 2350 Vosselaar.
When was the last time Reach Orphan Substances Consortium filed their annual financial statements?
The most recent financial statements of Reach Orphan Substances Consortium were filed on 01-07-2025.
How many employees does Reach Orphan Substances Consortium have?
There are currently no employees working at Reach Orphan Substances Consortium or no workforce information is available.
What is the annual turnover of Reach Orphan Substances Consortium?
At the time of its most recent financial statements, Reach Orphan Substances Consortium did not publish any turnover figures. Reach Orphan Substances Consortium reported a gross margin of -€1,861.32.